Jazz Pharmaceuticals plc Increase (Decrease) in Accrued Liabilities
Jazz Pharmaceuticals plc (JAZZ) reported Increase (Decrease) in Accrued Liabilities of $600.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-03
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $8.50M.
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$7.90M, a 104.36% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $26.17M, a 11.98% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $126.33M, a 147.58% increase year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for fiscal 2025 was $77.10M, a 10.52% decline from fiscal 2024.
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for fiscal 2024 was $86.16M.
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for fiscal 2023 was -$23.25M, a 114.00% decline from fiscal 2022.
- Jazz Pharmaceuticals plc increase (decrease) in accrued liabilities for fiscal 2022 was $165.99M, a 16.60% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $600.00K 10-Q · filed 2026-08-03 | $26.77M derived: sum of 3 quarters · filed 2026-08-03 | $153.10M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | -$7.90M 10-Q · filed 2026-05-05 | $18.27M derived: sum of 2 quarters · filed 2026-05-05 | $144.60M derived: sum of 3 quarters · filed 2026-05-05 | -$111.80M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $26.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $152.50M derived: sum of 2 quarters · filed 2026-02-24 | -$103.90M derived: sum of 3 quarters · filed 2026-08-03 | $77.10M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $126.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$130.07M derived: sum of 2 quarters · filed 2026-08-03 | $50.93M 10-Q · filed 2025-11-05 | $80.66M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | -$256.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$75.40M 10-Q · filed 2026-08-03 | -$75.35M 10-Q · filed 2025-08-06 | -$45.67M derived: sum of 3 quarters · filed 2026-08-03 | $5.36M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | $181.00M 10-Q · filed 2026-05-05 | $181.04M 10-Q · filed 2025-05-07 | $210.73M derived: sum of 2 quarters · filed 2026-05-05 | $261.75M derived: sum of 3 quarters · filed 2026-05-05 | $232.48M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $29.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $80.75M derived: sum of 2 quarters · filed 2026-02-24 | $51.48M derived: sum of 3 quarters · filed 2026-02-24 | $86.16M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $51.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $21.75M derived: sum of 2 quarters · filed 2025-11-05 | $56.43M 10-Q · filed 2025-11-05 | $109.44M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$29.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $5.40M 10-Q · filed 2025-08-06 | $58.42M derived: sum of 3 quarters · filed 2026-02-24 | $71.97M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $34.68M 10-Q · filed 2025-05-07 | $87.69M derived: sum of 2 quarters · filed 2026-02-24 | $101.24M derived: sum of 3 quarters · filed 2026-02-24 | $108.42M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $53.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $66.56M derived: sum of 2 quarters · filed 2026-02-24 | $73.74M derived: sum of 3 quarters · filed 2026-02-24 | -$23.25M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $13.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $20.72M derived: sum of 2 quarters · filed 2024-11-07 | -$76.26M 10-Q · filed 2024-11-07 | $71.87M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$89.81M 10-Q · filed 2024-08-01 | $58.32M derived: sum of 3 quarters · filed 2025-02-26 | $120.61M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | -$96.98M 10-Q · filed 2024-05-02 | $51.14M derived: sum of 2 quarters · filed 2025-02-26 | $113.44M derived: sum of 3 quarters · filed 2025-02-26 | $92.25M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $148.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $210.42M derived: sum of 2 quarters · filed 2025-02-26 | $189.23M derived: sum of 3 quarters · filed 2025-02-26 | $165.99M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $62.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $41.10M derived: sum of 2 quarters · filed 2023-11-08 | $17.86M 10-Q · filed 2023-11-08 | $66.69M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | -$21.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$44.43M 10-Q · filed 2023-08-09 | $4.39M derived: sum of 3 quarters · filed 2024-02-28 | $41.24M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | -$23.24M 10-Q · filed 2023-05-10 | $25.58M derived: sum of 2 quarters · filed 2024-02-28 | $62.43M derived: sum of 3 quarters · filed 2024-02-28 | $105.39M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $48.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $85.67M derived: sum of 2 quarters · filed 2024-02-28 | $128.64M derived: sum of 3 quarters · filed 2024-02-28 | $142.35M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $36.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $79.81M derived: sum of 2 quarters · filed 2022-11-09 | $93.53M 10-Q · filed 2022-11-09 | $146.50M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $42.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $56.69M 10-Q · filed 2022-08-03 | $109.66M derived: sum of 3 quarters · filed 2023-03-01 | $143.14M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $13.72M 10-Q · filed 2022-05-04 | $66.69M derived: sum of 2 quarters · filed 2023-03-01 | $100.17M derived: sum of 3 quarters · filed 2023-03-01 | $105.39M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $52.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $86.45M derived: sum of 2 quarters · filed 2023-03-01 | $91.67M derived: sum of 3 quarters · filed 2023-03-01 | $79.48M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $33.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $38.71M derived: sum of 2 quarters · filed 2021-11-09 | $26.51M 10-Q · filed 2021-11-09 | $58.31M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $5.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$6.97M 10-Q · filed 2021-08-03 | $24.83M derived: sum of 3 quarters · filed 2022-03-01 | $46.49M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$12.20M 10-Q · filed 2021-05-04 | $19.61M derived: sum of 2 quarters · filed 2022-03-01 | $41.27M derived: sum of 3 quarters · filed 2022-03-01 | -$14.03M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $31.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $53.47M derived: sum of 2 quarters · filed 2022-03-01 | -$1.83M derived: sum of 3 quarters · filed 2022-03-01 | -$5.57M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $21.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$33.64M derived: sum of 2 quarters · filed 2020-11-02 | -$37.37M 10-Q · filed 2020-11-02 | -$31.23M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | -$55.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$59.03M 10-Q · filed 2020-08-04 | -$52.90M derived: sum of 3 quarters · filed 2021-02-23 | -$47.93M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | -$3.73M 10-Q · filed 2020-05-05 | -$2.69M 10-Q · filed 2019-05-07 | $2.40M derived: sum of 2 quarters · filed 2021-02-23 | $7.37M derived: sum of 3 quarters · filed 2021-02-23 | $19.99M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2018-12-31 | $6.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $11.10M derived: sum of 2 quarters · filed 2021-02-23 | $23.72M derived: sum of 3 quarters · filed 2021-02-23 | $71.21M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $4.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $17.59M derived: sum of 2 quarters · filed 2019-11-05 | $65.07M 10-Q · filed 2019-11-05 | $82.08M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $12.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $60.11M 10-Q · filed 2019-08-06 | $77.11M derived: sum of 3 quarters · filed 2020-02-25 | $86.60M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $47.48M 10-Q · filed 2019-05-07 | $64.49M derived: sum of 2 quarters · filed 2020-02-25 | $73.98M derived: sum of 3 quarters · filed 2020-02-25 | $56.65M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $26.49M derived: sum of 2 quarters · filed 2020-02-25 | $9.16M derived: sum of 3 quarters · filed 2020-02-25 | -$6.58M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $9.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$7.84M derived: sum of 2 quarters · filed 2018-11-06 | -$23.58M 10-Q · filed 2018-11-06 | -$3.80M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$17.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$33.07M 10-Q · filed 2018-08-07 | -$13.29M derived: sum of 3 quarters · filed 2019-02-26 | -$17.35M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$15.74M 10-Q · filed 2018-05-08 | $4.04M derived: sum of 2 quarters · filed 2019-02-26 | -$20.00K derived: sum of 3 quarters · filed 2019-02-26 | $2.95M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $19.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $15.72M derived: sum of 2 quarters · filed 2019-02-26 | $18.70M derived: sum of 3 quarters · filed 2019-02-26 | $11.99M 10-K · filed 2019-02-26 | $10.13M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | -$4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.09M derived: sum of 2 quarters · filed 2017-11-07 | -$7.79M 10-Q · filed 2017-11-07 | -$9.65M 10-Q · filed 2016-11-08 | -$9.45M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$3.73M 10-Q · filed 2017-08-08 | -$5.59M 10-Q · filed 2016-08-09 | -$5.39M derived: sum of 3 quarters · filed 2018-02-27 | $17.39M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | -$6.71M 10-Q · filed 2017-05-09 | -$8.36M derived: sum of 2 quarters · filed 2018-02-27 | $14.41M derived: sum of 3 quarters · filed 2018-02-27 | $13.77M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $21.12M derived: sum of 2 quarters · filed 2018-02-27 | $20.47M derived: sum of 3 quarters · filed 2018-02-27 | $2.99M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $22.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $22.13M derived: sum of 2 quarters · filed 2016-11-08 | $4.64M 10-Q · filed 2016-11-08 | $6.17M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$18.14M 10-Q · filed 2016-08-09 | -$16.61M derived: sum of 3 quarters · filed 2017-02-28 | $3.68M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$17.48M 10-Q · filed 2016-05-10 | -$15.96M derived: sum of 2 quarters · filed 2017-02-28 | $4.33M derived: sum of 3 quarters · filed 2017-02-28 | $2.58M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $21.82M derived: sum of 2 quarters · filed 2017-02-28 | $20.07M derived: sum of 3 quarters · filed 2017-02-28 | $21.00M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $20.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $18.54M derived: sum of 2 quarters · filed 2015-11-09 | $19.47M 10-Q · filed 2015-11-09 | $32.62M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$821.00K 10-Q · filed 2015-08-05 | $12.33M derived: sum of 3 quarters · filed 2016-02-23 | $21.64M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $927.00K 10-Q · filed 2015-05-07 | $14.08M derived: sum of 2 quarters · filed 2016-02-23 | $23.39M derived: sum of 3 quarters · filed 2016-02-23 | $18.30M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $22.47M derived: sum of 2 quarters · filed 2016-02-23 | $17.38M derived: sum of 3 quarters · filed 2016-02-23 | $14.72M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | $9.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $4.22M derived: sum of 2 quarters · filed 2014-11-04 | $1.56M 10-Q · filed 2014-11-04 | $5.95M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | -$5.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$7.75M 10-Q · filed 2014-08-05 | -$3.37M derived: sum of 3 quarters · filed 2015-02-24 | -$29.95M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$2.66M 10-Q · filed 2014-05-08 | $1.72M derived: sum of 2 quarters · filed 2015-02-24 | -$24.86M derived: sum of 3 quarters · filed 2015-02-24 | -$7.55M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$22.20M derived: sum of 2 quarters · filed 2015-02-24 | -$4.89M derived: sum of 3 quarters · filed 2015-02-24 | -$11.43M 10-K · filed 2015-02-24 | -$1.64M 10-K · filed 2013-02-26 | |||
| 2012-09-30 | -$26.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$9.27M derived: sum of 2 quarters · filed 2013-11-05 | -$15.81M 10-Q · filed 2013-11-05 | $12.33M 10-Q · filed 2012-11-09 | -$16.86M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $17.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $10.77M 10-Q · filed 2013-08-06 | $16.34M 10-Q · filed 2012-08-07 | $9.72M derived: sum of 3 quarters · filed 2014-02-25 | $18.84M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | -$6.54M 10-Q · filed 2013-05-07 | -$7.59M derived: sum of 2 quarters · filed 2014-02-25 | $1.53M derived: sum of 3 quarters · filed 2014-02-25 | $4.97M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $8.07M derived: sum of 2 quarters · filed 2014-02-25 | $11.51M derived: sum of 3 quarters · filed 2014-02-25 | $11.21M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $9.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $12.56M derived: sum of 2 quarters · filed 2012-11-09 | $12.26M 10-Q · filed 2012-11-09 | $16.76M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $3.14M 10-Q · filed 2012-08-07 | $7.64M derived: sum of 3 quarters · filed 2013-02-26 | $10.81M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | -$298.00K 10-Q · filed 2012-05-08 | $4.20M derived: sum of 2 quarters · filed 2013-02-26 | $7.37M derived: sum of 3 quarters · filed 2013-02-26 | |||||
| 2010-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $7.67M derived: sum of 2 quarters · filed 2013-02-26 | $9.28M 10-K · filed 2013-02-26 | |||||
| 2010-09-30 | $3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $4.78M 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $1.61M 10-Q · filed 2011-08-03 | |||||||
| 2009-12-31 | -$6.68M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |